These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23230037)

  • 1. Leukopenia associated with long-term colchicine administration.
    Beggs AE; Reeves DJ; Noel NS
    Am J Health Syst Pharm; 2012 Dec; 69(24):2147-8. PubMed ID: 23230037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine-induced leukopenia successfully treated with lithium.
    Kutscher EC; Robbins GP; Kennedy WK; Zebb K; Stanley M; Carnahan RM
    Am J Health Syst Pharm; 2007 Oct; 64(19):2027-31. PubMed ID: 17893412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantation.
    Hamel S; Kuo V; Sawinski D; Johnson D; Bloom RD; Bleicher M; Goral S; Lim MA; Trofe-Clark J
    Clin Transplant; 2019 Jun; 33(6):e13541. PubMed ID: 30887581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
    Perrier L; Lefranc A; Pérol D; Quittet P; Schmidt-Tanguy A; Siani C; de Peretti C; Favier B; Biron P; Moreau P; Bay JO; Lissandre S; Jardin F; Espinouse D; Sebban C
    Appl Health Econ Health Policy; 2013 Apr; 11(2):129-38. PubMed ID: 23435861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of filgrastim (G-CSF) in Hodgkin's disease patients treated with radiation therapy.
    Knox SJ; Fowler S; Marquez C; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(2):445-50. PubMed ID: 7506247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial.
    Lambertini M; Bruzzi P; Poggio F; Pastorino S; Gardin G; Clavarezza M; Bighin C; Pronzato P; Del Mastro L
    Support Care Cancer; 2016 Mar; 24(3):1285-94. PubMed ID: 26306520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
    Shi YK; Sun Y; Su M
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):356-9. PubMed ID: 7895587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pegfilgrastim-induced hyperleukocytosis.
    Snyder RL; Stringham DJ
    Ann Pharmacother; 2007 Sep; 41(9):1524-30. PubMed ID: 17666580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Pegfilgrastim When Given Less Than 14 Days Before the Next Chemotherapy Cycle: Review of Every 14-Day Chemotherapy Regimen Containing 5-FU Continuous Infusion.
    Donkor KN; Selim JH; Waworuntu A; Lewis K
    Ann Pharmacother; 2017 Oct; 51(10):840-847. PubMed ID: 28597691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis.
    McKinnell J; Tayek JA
    J Clin Rheumatol; 2009 Sep; 15(6):303-5. PubMed ID: 19734738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
    Holmes FA; O'Shaughnessy JA; Vukelja S; Jones SE; Shogan J; Savin M; Glaspy J; Moore M; Meza L; Wiznitzer I; Neumann TA; Hill LR; Liang BC
    J Clin Oncol; 2002 Feb; 20(3):727-31. PubMed ID: 11821454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
    Shi YK; Feng FY; Sun Y
    Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):739-42. PubMed ID: 7541325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
    Shi YK; Zhou JC; Feng FY
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leukopenia due to anti-tuberculous chemotherapy including rifampicin and isoniazid].
    Nagayama N; Shishido Y; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2004 May; 79(5):341-8. PubMed ID: 15211874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind randomized controlled trial appraising the symptom-modifying effects of colchicine on osteoarthritis of the knee.
    Aran S; Malekzadeh S; Seifirad S
    Clin Exp Rheumatol; 2011; 29(3):513-8. PubMed ID: 21640042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effectiveness of biosimilar filgrastim (Nivestim™), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study.
    Brito M; Esteves S; André R; Isidoro M; Moreira A
    Support Care Cancer; 2016 Feb; 24(2):597-603. PubMed ID: 26111956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
    Shapiro CL; Ayash L; Webb IJ; Gelman R; Keating J; Williams L; Demetri G; Clark P; Elias A; Duggan D; Hayes D; Hurd D; Henderson IC
    J Clin Oncol; 1997 Feb; 15(2):674-83. PubMed ID: 9053493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study).
    Sebban C; Lefranc A; Perrier L; Moreau P; Espinouse D; Schmidt A; Kammoun L; Ghesquieres H; Ferlay C; Bay JO; Lissandre S; Pérol D; Michallet M; Quittet P
    Eur J Cancer; 2012 Mar; 48(5):713-20. PubMed ID: 22248711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 8: the major neutrophil chemotaxin in a case of pseudogout.
    Miller EJ; Brelsford WG
    J Rheumatol; 1993 Jul; 20(7):1250-2. PubMed ID: 8371232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colchicine-induced toxicity in a heart transplant patient with chronic renal failure.
    Eleftheriou G; Bacis G; Fiocchi R; Sebastiano R
    Clin Toxicol (Phila); 2008 Nov; 46(9):827-30. PubMed ID: 18608282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.